10
total announcements
539680.BO · 15 min delayed
Ganga Pharmaceuticals Ltd
Ganga Pharmaceuticals Ltd has issued a certificate in terms of Regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026.
Ganga Pharmaceuticals Ltd
Ganga Pharmaceuticals Ltd has announced the re-appointment of Mr. Bharat Brijmohan Sharma as Managing Director for a further period of three years effective from April 01, 2026. The re-appointment was approved by the Members of the Company at the 37th Annual General Meeting held on September 26, 2026.
Ganga Pharmaceuticals Ltd
Ganga Pharmaceuticals Ltd has announced the voting results of its 37th Annual General Meeting (AGM), along with the scrutinizer report.
Ganga Pharmaceuticals Ltd
Ganga Pharmaceuticals Ltd has announced the closure of its trading window from October 1, 2026, for all designated persons due to the upcoming declaration of unaudited financial results for the half year ending September 30, 2026.
Ganga Pharmaceuticals Ltd
Ganga Pharmaceuticals Ltd held its AGM on September 26, 2026, and the meeting was attended by the Chairman, Managing Director, and other officials. The meeting was conducted in accordance with the Companies Act, 2013, and the rules and regulations of the Stock Exchange. The meeting was adjourned to September 27, 2026, to consider the appointment of a new auditor.
Ganga Pharmaceuticals Ltd
Ganga Pharmaceuticals Ltd has published a newspaper advertisement in connection with its 37th Annual General Meeting (AGM) scheduled to be held on September 26, 2026.
Ganga Pharmaceuticals Ltd
Ganga Pharmaceuticals Ltd has sent a letter to shareholders whose email IDs are not registered with the RTA, providing a web link to access the AGM notice and annual report on the company's website.
Ganga Pharmaceuticals Ltd
Ganga Pharmaceuticals Ltd has announced the notice of its 37th Annual General Meeting (AGM) for the financial year 2025-26, to be held on September 26, 2026. The AGM will consider the adoption of audited financial statements, re-appointment of a director, and re-appointment of the Managing Director & CEO.
Ganga Pharmaceuticals Ltd
Ganga Pharmaceuticals Ltd has released its Annual Report for F.Y. 2025-26, providing insights into the company's financial performance and operations.
Ganga Pharmaceuticals Ltd
Ganga Pharmaceuticals Ltd has announced the schedule for its 37th Annual General Meeting (AGM) to be held on September 26, 2026.